Enrico Maria Surace
University of Pennsylvania
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Enrico Maria Surace.
Journal of Virology | 2003
Enrico Maria Surace; Alberto Auricchio; Samuel Jotham Reich; Tonia S. Rex; Ernest Glover; Stacey Pineles; Waixing Tang; Erin O'Connor; Arkady Lyubarsky; Andrey Savchenko; Edward N. Pugh; Albert M. Maguire; James M. Wilson; Jean Bennett
ABSTRACT The development of fetal ocular gene transfer may be useful as a therapeutic tool for the prevention of retinal genetic disorders with congenital or early clinical manifestations. In this study we explored the neural progenitor transduction patterns of adeno-associated virus (AAV) vectors following delivery to the developing retina. Recombinant vectors with the same genome carrying the enhanced green fluorescent protein (EGFP) transgene packaged in capsids of differing serotypes (serotypes 1, 2, and 5, termed AAV2/1, AAV2/2, and AAV2/5, respectively) were created. Delivery of the AAV vectors during early retinal development resulted in efficient and stable transduction of retinal progenitors. Vector surface proteins and the developmental status of the retina profoundly affected viral tropism and transgene distribution. The procedure is not detrimental to retinal development and function and therefore provides a safe delivery vehicle for potential therapeutic applications and a means of assessing the mechanisms of retina development and disease.
Journal of Gene Medicine | 2002
Thucanh T. Ho; Albert M. Maguire; Gustavo D. Aguirre; Enrico Maria Surace; Vibha Anand; Yong Zeng; Anna Salvetti; John J. Hopwood; Mark E. Haskins; Jean Bennett
Mucopolysaccharidosis VI (MPS VI), due to recessively inherited 4‐sulfatase (4S) deficiency, results in lysosomal storage of dermatan sulfate in numerous tissues. Retinal involvement is limited to the retinal pigment epithelium (RPE). This study aimed to determine whether recombinant adeno‐associated virus (AAV)‐mediated delivery of 4S would reverse the RPE pathology seen in MPS VI cats.
Advances in Experimental Medicine and Biology | 2003
Fong-Qi Liang; Enrico Maria Surace; Nadine S. Dejneka; M. Maguire Albert; Jean Bennett
Gene therapy for retinal diseases has gained increasing attention in recent years (see review, Bennett and Maguire, 2000). Among various gene delivery systems, viral vectors such as adenovirus (Ad), adeno-associated virus (AAV) and lentivirus appear to be the most efficient vehicles for gene transfer. In comparison to the Ad and lentivirus, AAV offers several advantages, including nonpathogenicity, minimal immuogenicity, and stable transgene expression in a wide host range (Flotte and Carter, 1995; Bennett et al., 1999; Anand et al., 2000
Archive | 2003
Samuel Jotham Reich; Enrico Maria Surace; Michael J. Tolentino
Molecular Therapy | 2004
Nadine S. Dejneka; Enrico Maria Surace; Tomas S. Aleman; Artur V. Cideciyan; Arkady Lyubarsky; Andrey Savchenko; T. Michael Redmond; Waixing Tang; Zhangyong Wei; Tonia S. Rex; Ernest Glover; Albert M. Maguire; Edward N. Pugh; Samuel G. Jacobson; Jean Bennett
Molecular Vision | 2001
Petros C. Karakousis; Sinoj K John; Kathryn C. Behling; Enrico Maria Surace; Julie E. Smith; Anita E. Hendrickson; Wai Xing Tang; Jean Bennett; Ann H. Milam
Molecular Vision | 2002
Kathryn C. Behling; Enrico Maria Surace; Jean Bennett
Archive | 2005
Alberto Auricchio; Markus Hildinger; Enrico Maria Surace
Archive | 2007
Alberto Auricchio; Enrico Maria Surace; Andrea Ballabio
Investigative Ophthalmology & Visual Science | 2004
Tonia S. Rex; J. Peet; Enrico Maria Surace; Alberto Auricchio; E. Bendo; Arkady Lyubarsky; Thomas E. Hughes; Albert M. Maguire; Jean Bennett; Edward N. Pugh